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ABSTRACT
The potential angiotensin-converting enzyme (ACE)–
inhibitory and antioxidant activities of peptides in wa-
ter-soluble extracts, obtained from raw and sterilized
ovine and caprine cheeselike systems coagulated with
enzymes from the plant Cynara cardunculus, were as-
sessed. Prior to the assay, the 3,000-Da permeate from
45-d-old cheeselike systems was fractionated by tan-
dem chromatographic techniques. Several peaks were
obtained in each chromatogram, but only some were
associated with ACE-inhibitory or antioxidant activity
or both. Peptides Tyr-Gln-Glu-Pro, Val-Pro-Lys-Val-
Lys, and Tyr-Gln-Glu-Pro-Val-Leu-Gly-Pro-* from β-ca-
sein, as well as Arg-Pro-Lys and Arg-Pro-Lys-His-Pro-
Ile-Lys-His-* from αs1-casein exhibited ACE-inhibitory
activity. Peptides released upon cleavage of the peptide
bond Leu190-Tyr191 (either in ovine or caprine β-ca-
sein), and corresponding to the β-casein sequence Tyr-
Gln-Glu-Pro-*, possessed antioxidant activity.
Key words: plant protease, ovine cheese, caprine
cheese, angiotensin-converting enzyme inhibition
INTRODUCTION
Biologically active peptides are of particular interest
in food science and nutrition, because they can play
several physiological roles. Hidden (or at least inactive)
within the AA sequence of dairy proteins, a class of
such peptides can be released (or activated) in vivo
during gastrointestinal digestion, or upstream during
food processing via specific, enzyme-mediated proteoly-
sis (Silva and Malcata, 2005a), and eventually be ab-
sorbed into the bloodstream.
Ripened cheese is one of the most important dairy
products worldwide. It typically contains numerous
peptides that originate mainly from CN breakdown dur-
ing ripening. Such peptides contribute to the flavor,
taste, and texture of the final product. Among the bioac-
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tivities attributed to those peptides are angiotensin-
converting enzyme (ACE)–inhibitory activity, opioid
activity, and the ability to sequester calcium and other
minerals; thus acting as biocarriers (Addeo et al., 1992;
Meisel et al., 1997; Smacchi and Gobbetti, 1998; Saito
et al., 2000; Go´mez-Ruiz et al., 2002; Sforza et al., 2003).
In the Iberian Peninsula, several raw ovine and cap-
rine milk cheeses, which are highly appreciated for
their unique organoleptic characteristics, have been
manufactured on the farm level since ancient times,
with extracts of the flowers of Cynara cardunculus as
the coagulant. After flowers are collected from mature
plants, they are dried in the open air in the shade before
use, stored in a dry place, and sold at local markets.
Their milk-clotting activity is caused by 2 aspartic pro-
teases, cardosins A and B, which resemble chymosin
and pepsin, respectively, in activity and specificity (Verı-
´ssimo et al., 1995). Cardosin A is a proteolytic enzyme
that is specific toward the Phe105-Met106 bond of κ-
CN, whereas cardosin B is a nonspecific, highly proteo-
lytic enzyme. No toxicity to humans has ever been found
for either of those enzymes. To our knowledge, no data
are currently available concerning bioactive peptides
from ovine or caprine milk cheeses manufactured with
plant enzymes; only the research efforts encompassing
the total antioxidant content of breast milk (Vander-
Jagt et al., 2001), the antioxidant activity of bovine
milk following 2 different analytical methods (Chen et
al., 2003), and evaluations of the antioxidant activity
of CN and CN-derived peptides (Suetsuna et al., 2000;
Rival et al., 2001).
In particular, ACE (EC 3.4.15.1) is important in blood
pressure regulation, so its inhibition may actually pre-
vent hypertension (Meisel, 1998). This dipeptidyl car-
boxypeptidase is a glycoprotein peptidyldipeptide hy-
drolase, which is able to release histidyl-leucine from
angiotensin I (a relatively inactive decapeptide) into
angiotensin II, thus increasing the blood pressure and
the alderosterone content, and inactivating the de-
pressor action of bradykinin. Peptides bearing ACE-
inhibitory activity have been found in several kinds of
cheeses (Addeo et al., 1992; Meisel et al., 1997; Smacchi
and Gobbeti, 1998; Saito et al., 2000; Go´mez-Ruiz et
al., 2002, 2004; Sforza et al., 2003). Their C-terminal
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tripeptide sequence is the structural feature governing
such inhibitory response (Maruyama et al., 1987). In
addition, Meisel (1993) indicated that the ACE-binding
pocket exhibits a preference for hydrophobic AA. To
measure ACE activity and inhibition thereof in vitro,
the method of Cushman and Cheung (1971) is often
used. This particularly sensitive spectrophotometric
assay determines the amount of hippuric acid formed
from hippuryl-L-histidyl-L-leucine via the action of
ACE. Recently, a (spectrophotometric) diagnostic assay
designed to measure ACE activity was transformed into
an enzyme inhibition assay and further optimized,
which led to a more sensitive yet less expensive assay;
it takes advantage of furanacryloyl-Phe-Gly-Gly as the
substrate, and uses rabbit lung acetone extract as stan-
dard of activity (Vermeirssen et al., 2002).
On the other hand, antioxidant activity is accounted
for by compounds able to protect biological systems
against the potential harmful effects of processes or
reactions that cause excessive degrees of oxidation, and
that may thus be responsible for cellular damage. Sev-
eral chemical and physicochemical methodologies have
been proposed and used to monitor oxidation processes;
some allow direct quantification of free radical produc-
tion and its inhibition by antioxidants, whereas others
indirectly assess the effectiveness of antioxidants in
preventing oxidative damage (Antolovich et al., 2002).
Accelerated stability tests, measurement of the ability
to bring about diene conjugation, the thiobarbituric
acid-reactive substance assay, measurement of hexanal
and related end products, and quantification of free
radicals are but a few examples. Among those of the
latest type, the 2,2′-azino-bis-(3-ethylbenzothiazoline)-
6-sulfonic acid (ABTS) assay is one of the most effective,
and hence is commonly used.
The aim of this work was thus to find and characterize
peptides with potential ACE-inhibitory and antioxidant
activities in raw and sterilized ovine and caprine
cheeselike systems, manufactured with enzymes from
C. cardunculus as the clotting agent.
MATERIALS AND METHODS
Enzyme Source
The plant proteases were obtained via maceration of
0.6 g of dry flowers of C. cardunculus in 10 mL of water.
The solution was then kept refrigerated until use (no
filtration was needed, as it remained limpid).
Cardosins in the aforementioned crude extract of C.
cardunculus were isolated and purified, following the
procedure described by Silva et al. (2003). The lyophi-
lized enzymes were reconstituted in water, just prior
to use, up to 0.0035 kg/L.
Journal of Dairy Science Vol. 89 No. 9, 2006
Cheese Making and Sampling
Ovine (or caprine) milk was collected from the sheep
(or goat) flocks on the morning of cheese making. Each
batch of milk was then divided in 2 equal portions: one
portion was heated at 110°C for 10 min, whereas the
other received no thermal treatment. Milk sterility (for
the first batch) was checked as the absence of microor-
ganisms on plate count agar incubated at 30°C for 48
h (Tavaria and Malcata, 1998). Cheeses were manufac-
tured on the same day from raw ovine (or caprine) milk,
and from sterilized ovine (or caprine) milk. Portions of
50 mL of each kind of milk (ovine or caprine) were
placed in 100-mL sterilized flasks; then 0.200 mL of
test enzyme solution (crude aqueous extract, or purified
cardosin A or B) was added to the milk under sterile
conditions and incubated at 28°C until coagulation oc-
curred (approximately 45 min). The curd was then cut,
stirred, and allowed to set to permit draining, again
under sterile conditions. The whey produced was re-
moved aseptically by opening the flasks every 15 min
throughout a period of 1.5 h. The flasks were placed in
a chamber maintained at 10°C. For further analyses,
45-d-old cheeses were selected at random.
Preparation of Water-Soluble Extracts
Water-soluble extracts (WSE) and water-insoluble
extracts of cheeselike systems were prepared following
the procedure of Kuchroo and Fox (1982). The cheese-
like system was homogenized in a stomacher (Seward,
London, UK) at 20°C for 10 min with twice its weight
of water. The slurry was held at 40°C for 1 h, and then
centrifuged at 3,000 × g, at 4°C for 30 min. The resulting
supernatants were filtered through glass wool, freeze-
dried, and kept at −20°C until use.
A 20-mg quantity of WSE was reconstituted in 600L
of water, and 500 L of this solution was then filtered
through a Centriprep hydrophilic 3,000-Da cutoff mem-
brane (Amicon, Beverly, MA) prior to analysis.
Purification of Peptides
The freeze-dried WSE samples (10 mg) were dis-
solved in 1 mL of 50% (vol/vol) trifluoroacetic acid (TFA)
in water and filtered through a 0.45-m cellulose ace-
tate filter. This solution was used to further fractionate
the peptides present in the WSE. Aliquots (100 L)
were applied to a reversed-phase column (SuperPak
Pep-S, 4.0 × 250 mm, 5 m, after a Pep-S precolumn,
4.0 × 10 mm, 5 m, both from Pharmacia, Uppsala,
Sweden). Elution was at 40°C via a mobile phase of 2
solvents—solvent A: 0.05% (vol/vol) TFA in water; and
solvent B: 0.05% (vol/vol) TFA in acetonitrile:water
(9:1)—at a flow rate of 1.0 mL/min, starting with 98%
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Table 1. Average angiotensin-converting enzyme–inhibitory activity (%) of water-soluble extracts of raw and sterilized ovine and caprine
cheeselike systems, manufactured separately with cardosin A, cardosin B, or a crude aqueous extract of Cynara cardunculus
Ovine milk Caprine milk
Raw Sterilized Raw Sterilized
Protein, Protein, Protein, Protein,
Coagulant mg/mL Inhibition, % mg/mL Inhibition, % mg/mL Inhibition, % mg/mL Inhibition
Cardosin A 0.67 6.21 ± 0.07 0.99 6.21 ± 0.09 2.32 44.95 ± 0.20 1.33 16.57 ± 0.04
Cardosin B 1.34 50.86 ± 0.15 0.80 12.57 ± 0.11 2.38 79.43 ± 0.08 1.43 33.71 ± 0.11
Crude aqueous extract
of C. cardunculus 1.84 62.29 ± 0.06 1.34 40.11 ± 0.08 2.30 63.43 ± 0.04 0.34 48.00 ± 0.13
(vol/vol) solvent A, passing through a linear gradient
from 2 to 60% (vol/vol) solvent B over 45 min, another
linear gradient from 60 to 100% (vol/vol) solvent B for
2 min, 100% (vol/vol) solvent B for 5 min, and a linear
gradient from 98 to 2% (vol/vol) solvent B for 2 min,
and ending with 2% (vol/vol) solvent B for 2 min. Detec-
tion was by spectrophotometry at 214 nm. The fractions
were collected based on their peak assignments. This
step was repeated 5 times, and the fractions from the
various chromatographic runs were pooled and dried
in a vacuum.
Estimation of ACE-Inhibitory Activity
Inhibition of ACE was assayed by the method of Ver-
meirssen et al. (2002). The ACE reagent (containing
0.5 mmol/L of N-[3-(2-furyl)acryloyl]-L-phenylalanyl-
glycylglycine, with stabilizer and buffer at pH 8.2;
Sigma, St. Louis, MO) was reconstituted in 5 mL of
water. The ACE from rabbit lung (Sigma) was reconsti-
tuted with demineralized water (0.2 U/mL) and diluted
to 1:3 (vol/vol) before use.
Each aliquot (125L) of sample was mixed and prein-
cubated, at 37°C for 2 min, with 125 L of ACE reagent.
After adding 25 L of ACE reagent to this suspension,
the reaction mixture was further incubated at 37°C
for 5 min. Subsequently, absorbance at 340 nm was
measured against demineralized water (control) in the
heated cuvette holder (37°C) of a UV-visible spectropho-
tometer, over a time interval of 10 min.
The inhibitory activity was expressed as the percent-
age of ACE inhibition per milligram of protein, except
for WSE, in which the activity was calculated as the
amount of water-soluble nitrogen needed to inhibit 50%
of ACE activity (IC50). The activity of each sample was
tested in triplicate, and their average was used as a
datum point. A positive control (1 mM captopril;
Sigma), which is known to inhibit ACE, was also in-
cluded in the assay program.
Estimation of Antioxidant Activity
The antioxidant activity of either WSE or the isolated
peptides thereof was assayed according to the method
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described by Re et al. (1999). 2,2′-Azino-bis-(3-ethylben-
zothiazoline)-6-sulfonic acid was dissolved in water to
a 7 mM concentration. To prepare the ABTS•+ radical
specifically needed for this test, the ABTS aqueous solu-
tion was oxidized via treatment with 2.45 mM pot-
assium persulfate (1:0.5) for 12 to 16 h in the dark, and
then diluted in 0.1 mol/L of phosphate buffer (pH 7.4)
prior to assaying, which yielded a typical absorbance
of 0.70 ± 0.02 at 734 nm after equilibration at 30°C. A
10-L quantity of sample (or Trolox, as positive control)
was added to 1 mL of diluted ABTS•+ solution and
incubated at 30°C for 10 min. Scavenging of the ABTS•+
radical was followed by monitoring the decrease in ab-
sorbance at 734 nm. A reading was taken 1 min after
initial mixing and then periodically up to 6 min. A
solvent blank was run in each assay (negative control).
All determinations were carried out in triplicate, and
their average was used as a datum point. The percent-
age inhibition of absorbance at 734 nm was calculated
and plotted as a function of the concentration of the
reference antioxidant (Trolox).
Sequencing of Peptides
The peptides that exhibited ACE-inhibitory activity
were sequenced by Edman degradation using a model
491 automated, pulsed liquid-phase protein-peptide se-
quencer (Applied Biosystems, Foster City, CA). The AA
released were detected as their phenylthiohydantoin
derivatives. The partial sequence thus obtained was
checked against the (known) sequence of CN in refer-
ence databases (BLAST at the National Center for Bio-
technology Information, http://www.ncbi.nlm.nih.gov/
BLAST), in attempts to identify the specific peptide
bonds cleaved by the enzymes under consideration.
Determination of Protein Content
The protein (peptide) concentrations were deter-
mined by the phenol reagent method for biological fluids
using the Micro Protein Determination kit (Sigma).
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Table 2. Molecular characteristics of peptides identified in the permeate of water-soluble extracts of raw and sterilized ovine cheeselike
systems, manufactured separately with cardosin A, cardosin B, or a crude aqueous extract of Cynara cardunculus, and corresponding
angiotensin-converting enzyme (ACE)-inhibitory and antioxidant activities1
Protein ACE-inhibitory Antioxidant
Peptide bond concentration, activity, activity,
Peak cleaved Sequence mg/mL IC50 (g/mL) TEAC (mM)
Raw system
A ND ND 0.180 112.76 ± 0.15 ND
B ND ND 0.660 661.04 ± 0.07 0.095 ± 0.06
C β-CN [Gly94-Val95] Val-Pro-Lys-Val-Lys 0.090 93.75 ± 0.06 0.079 ± 0.15
αs1-CN Arg-Pro-Lys
D β-CN [Leu190-Tyr191] Tyr-Gln-Glu-Pro 0.170 169.86 ± 0.10 0.102 ± 0.10
β-CN [Met102-Val103] Val-Pro-Lys-His
β-CN [Asn73-Ile74] Ile-Leu-Pro
Sterilized system
E ND ND 0.070 65.46 ± 0.05 ND
F β-CN [Leu190-Tyr191] Tyr-Gln-Glu-Pro-Val-Leu-Gly-Pro-* 0.500 499.99 ± 0.04 0.124 ± 0.11
Captopril — — — 0.00 ± 0.12 —
1Peaks shown in Figure 1. IC50 = amount of water-soluble nitrogen needed to inhibit 50% of ACE activity; TEAC = Trolox-equivalent
antioxidant capacity; ND = not determined.
RESULTS AND DISCUSSION
Data pertaining to the ACE-inhibitory activity of the
WSE from ovine and caprine milk cheeselike systems
manufactured with the various coagulants, namely car-
dosin A, cardosin B, and crude aqueous extracts of C.
cardunculus, are presented in Table 1. Typical elution
profiles of the 3,000-Da permeate from raw and steri-
lized ovine and caprine milk cheeselike systems, manu-
factured with the aforementioned coagulants, are
shown in Figures 1 and 2. The results obtained via
sequencing, as well as those referring to protein con-
tent, ACE-inhibitory activity, and antioxidant activity
Table 3. Molecular characteristics of peptides identified in the permeate of water-soluble extracts of raw and sterilized caprine cheeselike
systems, manufactured separately with cardosin A, cardosin B, or a crude aqueous extract of Cynara cardunculus, and corresponding
angiotensin-converting enzyme (ACE)-inhibitory and antioxidant activities1
Protein ACE-inhibitory Antioxidant
Peptide bond concentration, activity, activity,
Peak cleaved Sequence mg/mL IC50 (g/mL) TEAC (mM)
Raw system
G ND ND 0.710 705.70 ± 0.11 0.064 ± 0.05
H ND ND 0.140 143.59 ± 0.13 0.069 ± 0.03
I ND ND 0.220 216.63 ± 0.15 0.073 ± 0.02
J β-CN [Leu190-Tyr191] Tyr-Gln-Glu-Pro 0.690 689.40 ± 0.18 0.072 ± 0.06
K αs1-CN Arg-Pro-Lys-His-Pro-Ile-Lys-His-* 0.503 892.83 ± 0.11 ND
Sterilized system
L ND ND 0.001 0.580 ± 0.04 ND
M β-CN [Gly94-Val95] Val-Pro-Lys-Val-Lys 0.004 2.45 ± 0.13 ND
αs1-CN Arg-Pro-Lys 0.062 36.68 ± 0.13 ND
N ND ND
O αs2-CN [Phe89-Tyr90] Tyr-Gln-Lys-Phe-Pro-Gln-Tyr 0.100 95.46 ± 0.18 0.068 ± 0.02
P ND ND 0.291 161.41 ± 0.07 ND
Q ND ND 0.202 116.92 ± 0.24 ND
R β-CN [Leu190-Tyr191] Tyr-Gln-Glu-Pro-Val-Leu-Gly-Pro-* 0.650 653.98 ± 0.22 0.191 ± 0.05
Captopril — — — 0.00 ± 0.12 —
1Peaks shown in Figure 2. IC50 = amount of water-soluble nitrogen needed to inhibit 50% of ACE activity; TEAC = Trolox-equivalent
antioxidant capacity; ND = not determined.
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of the peptides isolated by HPLC, are depicted in Tables
2 and 3.
The most obvious differences between the peptide
profiles in Figures 1 and 2 can be ascribed to the use
of raw vs. sterilized milk. Heat treatment of cheese-
making milk is intended to ensure the safety of the
feedstock and the final product via elimination of adven-
titious, pathogenic microflora (Hermier and Cerf, 2000).
Furthermore, cheese makers sometimes heat milk prior
to cheese manufacture to increase cheese yield (Calvo
et al., 1992). However, interactions of whey proteins
with CN micelles brought about by heating milk do
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Figure 1. Reversed-phase HPLC chromatograms of the 3,000-Da permeate of water-soluble extracts of (A) raw and (B) sterilized ovine
cheeselike systems, manufactured separately with cardosin A, cardosin B, or a crude aqueous extract of Cynara cardunculus. Peaks labeled
A to F correspond to peptides identified in Table 2.
interfere with the rennet coagulation process, hence
leading to longer coagulation times as well as weaker
curd structures (Dalgleish, 1987; Banks, 1990; Singh
and Waungana, 2001). The resulting cheese is known to
tend to develop an atypical flavor and texture afterward
during ripening, which in turn depends quantitatively
mainly on the extent of proteolysis and qualitatively on
the profile of proteolysis. In such a case, the coagulant
retained in the curd is mainly responsible for CN break-
down, which may account for the results obtained as
compared with those of raw milk, in which the mi-
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croflora also play an important role (especially in terms
of secondary proteolysis).
Higher ACE-inhibitory activity was found in the WSE
of cheeselike systems obtained from raw rather than
sterilized milk, and a higher IC50 against ACE was
detected for caprine rather than ovine cheeselike sys-
tems (in which the extent of enzyme-mediated proteoly-
sis was also higher). Similar results were found by Silva
and Malcata (2005b) concerning proteolysis of ovine vs.
caprine milk CN via enzymes contributed by C. car-
dunculus.
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Figure 2. Reversed-phase HPLC chromatograms of the 3,000-Da permeate of the water-soluble extracts of (A) raw and (B) sterilized
caprine cheeselike systems, manufactured separately with cardosin A, cardosin B, or a crude aqueous extract of Cynara cardunculus. Peaks
labeled G to R correspond to peptides identified in Table 3.
Among the 3 types of coagulants tested, the lowest
effect was noticed in cheeselike systems produced with
cardosin A, and the highest with the crude aqueous
extract. Cardosin A is the most abundant cardosin in
crude aqueous extracts of C. cardunculus (Fraza˜o et
al., 1999); its specificity is believed to be similar to that
of chymosin. Cardosin B resembles pepsin in terms of
kinetic behavior (Verı´ssimo et al., 1995) and is also
known to possess nonspecific proteolytic activity. In the
crude aqueous extract, a synergistic action apparently
takes place between the 2 cardosins, which could ex-
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plain the actual results obtained. Concerning the pep-
tide profile of the corresponding WSE (Figures 1 and
2), several peaks appear in each chromatogram, but
only some of them show ACE-inhibitory or antioxidant
activities or both (Tables 2 and 3).
In raw ovine cheeselike systems, only 4 peptides were
found to have ACE-inhibitory activity. All of them were
produced via the action of cardosin B, either as such or
as a crude mixture in the aqueous extract of C. cardun-
culus, whereas only one was formed in cheeselike sys-
tems manufactured with cardosin A. The peptide de-
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noted as C had the highest activity (IC50 = 93.75 g/
mL), whereas the peptide denoted as B possessed the
lowest (IC50 = 661.04 g/mL).
Very few peptides were present in the 3,000-Da per-
meate of sterilized ovine cheeselike systems, and only 2
peptides were shown to possess ACE-inhibitory activity
(IC50 = 65.46 for the peptide denoted as E, and IC50 =
499.99 g/mL for the peptide denoted as F). Several
peptides were found in the corresponding permeate of
raw caprine cheeselike systems, but only 5 inhibited
ACE activity. The peptide denoted as K possessed the
lowest activity (IC50 = 892 g/mL), whereas the peptide
denoted as H exhibited the highest activity (IC50 =
143.70 g/mL).
Seven peptides present in the WSE of sterilized cap-
rine cheeselike systems manufactured via crude aque-
ous extracts of C. cardunculus (denoted as L through
R) were shown to have ACE-inhibitory activity. The
highest activities were accounted for by peptides L
(IC50 = 0.58 g/mL) and M (IC50 = 2.45 g/mL), whereas
peptide R exhibited the lowest activity (IC50 = 653.98
g/mL). Peptide Q (IC50 = 116.92 g/mL) was not found
in cheeselike systems made with cardosin A.
Chemical sequencing permitted us to determine the
peptide bonds cleaved by the coagulating enzymes
within CN, from (putative) identification of the peptides
(or at least by part of their sequence) released. However,
some chromatographic peaks were accounted for by a
major peptide accompanied by other minor components
(i.e., a mixture of peptides), which made the analysis
increase considerably in complexity.
Peptide bonds in β-CN cleaved by enzymes from C.
cardunculus included Leu190-Tyr191, Gly94-Val95,
Met102-Val103, and Asn73-Ile74, which gave rise to
the peptides Tyr-Gln-Glu-Pro, Ile-Leu-Pro, Val-Pro-
Lys-Val-Lys, and Tyr-Gln-Glu-Pro-Val-Leu-Gly-Pro-*
(see Tables 2, 3). Peptide Tyr-Gln-Glu-Pro-Val-Leu, also
found in hydrolyzed bovine milk, was demonstrated to
have ACE-inhibitory activity, characterized by an IC50
of 280 M (Pihlanto-Leppa¨la¨ et al., 1998).
In the case of αs1-CN, N-terminal peptides were iden-
tified that exhibited ACE-inhibitory activity, namely,
Arg-Pro-Lys [αs1-CN (1-3)] and Arg-Pro-Lys-His-Pro-
Ile-Lys-His-* [αs1-CN (1-*)]. When studying a new type
of ripened, low-fat cheese, Ryha¨nen et al. (2001) also
reported that similar peptides from αs1-CN [i.e., αs1-CN
(1-9), αs1-CN (1-7), and αs1-CN (1-6)] possessed ACE-
inhibitory activity. Moreover, Saito et al. (2000) found
αs1-CN (1-9) from Gouda cheese among the peptides
bearing ACE-inhibitory activity (IC50 = 13.4M), which
also showed a weak antihypertensive activity in sponta-
neously hypertensive rats.
Structure–activity studies involving various peptides
that can inhibit ACE indicate that their binding thereto
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is strongly influenced by the hydrophobicity and steric
size of the AA in the C-terminal position of the peptide
(Gobetti et al., 2004; Pripp et al., 2004, 2006). In addi-
tion, Cheung et al. (1980) have claimed that ACE pre-
fers substrates or competitive inhibitors that contain
such hydrophobic AA residues as Pro, Phe, and Tyr
in the C-terminus. Among the peptides experimentally
proven to possess ACE-inhibitory activity, only the se-
quence Tyr-Gln-Glu-Pro has those characteristics; how-
ever, Tyr-Gln-Glu-Pro-Val-Leu-Gly-Pro-* may be seen
as a precursor of the previous shorter sequence.
Finally, one should emphasize that bioactivity per
unit weight of cheese might be more relevant for con-
sumers than the inhibitory strength of peptide fractions
isolated from cheese, which will make a difference con-
cerning any health claims of ACE inhibition (Pripp et
al., 2006).
The Trolox-equivalent antioxidant capacity (TEAC)
assay is based on scavenging of ABTS•+, with concomi-
tant conversion thereof to a colorless product. The de-
gree of decolorization induced by a compound relates
to that induced by Trolox, thus yielding a TEAC value,
which is often used as a useful tool to detect (unknown)
antioxidants (Arts et al., 2004). The TEAC values found
for peptides isolated from WSE of raw and sterilized
ovine and caprine cheeselike systems are shown in Ta-
bles 1 and 2. Although most peptides exhibit low TEAC
values compared with those ofα-tocopherol and vitamin
C (0.97 and 0.99 mM, respectively, by 6 min; Miller et
al., 1993), higher TEAC values were generally found
for peptides in WSE from ovine cheeselike systems.
Peptides D, F, and R, from WSE of raw ovine, steri-
lized ovine, and sterilized caprine cheeselike systems,
respectively, presented the highest TEAC values
(0.102, 0.124, and 0.191 mM, respectively). A compari-
son of the TEAC values of such peptides with the TEAC
values of others found in the literature (using the
ABTS•+ method) indicates that their antioxidant capac-
ity is comparable to that of some sherry wines (Villa˜no
et al., 2004). The aforementioned peptides arise from
cleavage of the peptide bond Leu190-Tyr191, either in
ovine or caprine β-CN, and correspond to the sequence
Tyr-Gln-Glu-Pro-*. Such a realization is of great impor-
tance, because there are no reports to date concerning
peptides from cheeses bearing this kind of bioactivity.
This provides useful information toward the develop-
ment of functional food products in the near future, and
of additives with proven antioxidant properties.
Difficulties in peptide identification constrain the
knowledge encompassing bioactive peptide formation
and their release from the precursor proteins. In fact,
milk protein hydrolysates are highly complex mixtures
that may contain up to hundreds of different peptides.
Therefore, identification of such peptides in fermented
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dairy products or in milk protein hydrolysates gener-
ated by the action of nonspecific enzymes is a labor-
intensive and difficult task. This task comprises several
purification steps, normally a combination of distinct
(and complementary) chromatographic techniques.
Each separation step in turn requires solvent removal
and assessment of biological activity. In most cases, the
final fractions still contain multiple components, which
can cause a discrepancy between the activity exhibited
by the purified fractions and that by their original coun-
terparts (Go´mez-Ruiz et al., 2002; Gobbetti et al., 2004).
CONCLUSIONS
Raw and sterilized ovine and caprine cheeselike sys-
tems, manufactured with proteases from C. carduncu-
lus, are a source of peptides with ACE-inhibitory and
antioxidant activities. The peptides Tyr-Gln-Glu-Pro,
Val-Pro-Lys-Val-Lys, and Tyr-Gln-Glu-Pro-Val-Leu-
Gly-Pro-* from β-CN, as well as Arg-Pro-Lys and Arg-
Pro-Lys-His-Pro-Ile-Lys-His-* from αs1-CN exhibited
ACE-inhibitory activity. Peptides released upon cleav-
age of the peptide bond Leu190-Tyr191 (either in ovine
or caprine β-CN), and corresponding to the β-CN se-
quence Tyr-Gln-Glu-Pro-*, possessed antioxidant activ-
ity. Despite their moderate bioactivity, they intrinsi-
cally behave as functional foods, so they may eventually
be recommended for inclusion in one’s daily diet as a
more appealing, health-promoting vector than the di-
rect use of more potent drugs. Moreover, possibilities
exist for designing new dietary products as well as for
exploiting novel natural drugs, because peptide se-
quences not previously described in the literature pos-
sess such desired bioactivities.
ACKNOWLEDGMENTS
Financial support for author S. V. Silva was provided
by a PhD fellowship (BD/18479/98) issued by the pro-
gram PRAXIS XXI [Fundac¸a˜o para a Cieˆncia e Tecno-
logia (FCT), Portugal]. This research effort received
partial financial support by grants associated with proj-
ects “Enterococos: Aprofundamento do conhecimento
sobre o papel desempenhado por enterococos no fabrico
e na maturac¸a˜o natural de queijos tradicionais portu-
gueses” (POCTI/AGR/36165/99) and “MICROCHEESE:
MICro-stRucture of pOrtuguese CHEESEs” (POCTI/
36197/BIO/2000), both issued by the program POCTI
(FCT). The availability of laboratory facilities at MTT
Agrifood Research Finland is hereby gratefully ac-
knowledged.
REFERENCES
Addeo, F., L. Chianese, A. Salzano, R. Sacchi, U. Cappuccio, P. Fer-
ranti, and A. Malorni. 1992. Characterization of the 12% trichloro-
Journal of Dairy Science Vol. 89 No. 9, 2006
acetic acid-insoluble oligopeptides of Parmigiano–Reggiano
cheese. J. Dairy Res. 59:401–411.
Antolovich, M., P. D. Prenzler, E. Patsalides, S. McDonald, and K.
Robards. 2002. Methods for testing antioxidant activity. Analyst
127:183–198.
Arts, M. J. T. J., G. R. M. M. Haenen, H.-P. Voss, and A. Bast. 2004.
Antioxidant capacity of reaction products limits the applicability
of the Trolox equivalent antioxidant capacity (TEAC) assay. Food
Chem. Toxicol. 42:45–49.
Banks, J. M. 1990. Improving cheese yield by the incorporation of
whey powder. Dairy Ind. Int. 55:37–39.
Calvo, M. M., J. Leaver, A. J. R. Law, and J. M. Banks. 1992. Changes
in casein levels during the ripening of Cheddar type cheese made
from overheated milk. Milchwissenschaft 47:516–518.
Chen, J., H. Lindmark-Ma˚nsson, L. Gorton, and B. A˚kesson. 2003.
Antioxidant capacity of bovine milk as assayed by spectrophoto-
metric and amperometric methods. Int. Dairy J. 13:927–935.
Cheung, H. S., F. I. Wang, M. A. Ondetti, E. F. Sabo, and D. W.
Cushman. 1980. Binding of peptide substrates and inhibitors of
angiotensin-converting enzyme. Importance of the COOH-termi-
nal dipeptide sequence. J. Biol. Chem. 225:401–407.
Cushman, D. W., and H. S. Cheung. 1971. Spectrophotometric assay
and properties of the angiotensin-converting enzyme of rabbit
lung. Biochem. Pharmacol. 20:1637–1648.
Dalgleish, D. G. 1987. The enzymatic coagulation of milk. Pages 63–
96 in Cheese: Chemistry, Physics and Microbiology. P. F. Fox,
ed. Elsevier, London.
Fraza˜o, C., I. Bento, J. Costa, C. M. Soares, P. Verı´ssimo, C. Faro,
E. Pires, J. Cooper, and M. A. Carrondo. 1999. Crystal structure
of cardosin A, a glycosylated and Arg-Gly-Asp-containing aspartic
proteinase from the flowers of Cynara cardunculus L. J. Biol.
Chem. 274:27694–27701.
Gobetti, M., L. Stepaniak, M. de Angelis, A. Corsetti, and R. di Cagno.
2004. Latent bioactive peptides in milk proteins: Proteolytic acti-
vation and significance in dairy processing. Crit. Rev. Food Sci.
Nutr. 42:223–239.
Go´mez-Ruiz, J. A., M. Ramos, and I. Recio. 2002. Angiotensin-con-
verting enzyme-inhibitory peptides in Manchego cheeses manu-
factured with different starter cultures. Int. Dairy J. 12:697–706.
Go´mez-Ruiz, J. A., M. Ramos, and I. Recio. 2004. Angiotensin con-
verting enzyme-inhibitory activity of peptides isolated from Man-
chego cheese. Stability under simulated gastrointestinal diges-
tion. Int. Dairy J. 12:1075–1080.
Hermier, J., and O. Cerf. 2000. Heat treatments. Pages 239–254 in
Cheesemaking—From Science to Quality Assurance. A. Eck and
J.-C. Gillis, ed. Lavoisier, Paris, France.
Kuchroo, C. N., and P. F. Fox. 1982. Comparison of extraction proce-
dures. Milchwissenschaft 37:331–335.
Maruyama, S., H. Mitachi, J. Awaya, M. Kurono, N. Tonizuka, and
H. Suzuki. 1987. Angiotensin I-converting enzyme inhibitory ac-
tivity of the C-terminal hexapeptide of αs1-casein. Agric. Biol.
Chem. 51:2557–2561.
Meisel, H. 1993. Casokinins as bioactive peptides in the primary
structure of casein. Pages 67–75 in Food Proteins: Structure and
Functionality. K. D. Schwenke and R. Mothes, ed. VCH-Wein-
heim, New York, NY.
Meisel, H. 1998. Overview on milk protein-derived peptide. Int. Dairy
J. 8:363–373.
Meisel, H., A. Goepfert, and S. Gu¨nther. 1997. ACE-inhibitory activi-
ties in milk products. Milchwissenschaft 52:307–311.
Miller, N. J., C. A. Rice-Evans, M. J. Davies, V. Gopinathan, and A.
Milner. 1993. A novel method for measuring antioxidant capacity
and its application to monitoring the antioxidant status in prema-
ture neonates. Clin. Sci. 84:407–412.
Pihlanto-Leppa¨la¨, A., T. Rokka, and H. Korhonen. 1998. Angiotensin
I-converting enzyme inhibitory peptides derived from bovine milk
proteins. Int. Dairy J. 8:325–331.
Pripp, A. H., T. Isaksson, L. Stepaniak, and T. Sørhaug. 2004. Quanti-
tative structure–activity relationship modelling of ACE inhibitory
peptides derived from milk proteins. Eur. Food Res. Technol.
219:579–583.
SILVA ET AL.3344
Pripp, A. H., R. Sørensen, L. Stepaniak, and T. Sørhaug. 2006. Rela-
tionship between proteolysis and angiotensin-I–converting en-
zyme inhibition in different cheeses. LWT Food Sci. Technol.
39:677–683.
Re, R., N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C.
Rice-Evans. 1999. Antioxidant activity applying an improved
ABTS radical cation decolorization assay. Free Radic. Biol. Med.
26:1231–1237.
Rival, S. G., C. G. Boerium, and H. J. Wichers. 2001. Caseins and
casein hydrolysates. 2. Antioxidative properties and relevance to
lipoxygenase inhibition. J. Agric. Food Chem. 49:295–302.
Ryha¨nen, E.-L., A. Pihlanto-Leppa¨la¨, and E. Pahkala. 2001. A new
type of ripened, low-fat cheese with bioactive properties. Int.
Dairy J. 11:441–447.
Saito, T., T. Nakamura, H. Kitazawa, Y. Kawai, and T. Itoh. 2000.
Isolation and structural analysis of antihypertensive peptides
that exist naturally in Gouda cheese. J. Dairy Sci. 83:1434–1440.
Sforza, S., L. Ferroni, G. Galaverna, A. Dossena, and R. Marchelli.
2003. Extraction, semi-quantification, and fast on-line identifica-
tion of oligopeptides in Grana-Padano cheese by HPLC-MS. J.
Agric. Food Chem. 5:2130–2135.
Singh, H., and A. Waungana. 2001. Influence of heat treatment of
milk on cheesemaking properties. Int. Dairy J. 11:543–551.
Silva, S. V., T. Allmere, F. X. Malcata, and A. Andre´n. 2003. Compara-
tive studies on the gelling properties of cardosins from Cynara
cardunculus and chymosin on cow’s skim milk. Int. Dairy J.
13:559–564.
Silva, S. V., and F. X. Malcata. 2005a. Milk caseins as a source of
bioactive peptides. Int. Dairy J. 15:1–15.
Journal of Dairy Science Vol. 89 No. 9, 2006
Silva, S. V., and F. X. Malcata. 2005b. Studies pertaining to coagulant
and proteolytic activities of plant proteases from Cynara cardun-
culus. Food Chem. 89:19–26.
Smacchi, E., and M. Gobetti. 1998. Peptides from several Italian
cheeses inhibitory to proteolytic enzymes of lactic acid bacteria
Pseudomonas fluorescens ATCC 948 and to the angiotensin I-
converting enzyme. Enzyme Microb. Technol. 22:687–694.
Suetsuna, K., H. Ukeda, and H. Ochi. 2000. Isolation and character-
ization of free radical scavenging activities of peptides derived
from casein. J. Nutr. Biochem. 11:128–131.
Tavaria, F. K., and F. X. Malcata. 1998. Microbiological characteriza-
tion of Serra da Estrela cheese throughout its Appe´lation d’Ori-
gine Prote´ge´e Region. J. Food Prot. 61:601–607.
VanderJagt, D. J., S. N. Okolo, A. Constanza, W. Blackwell, and R.
H. Glew. 2001. Antioxidant content of the milk of Nigerian women
and the sera of their exclusively breast-fed infants. Nutr. Res.
21:121–128.
Verı´ssimo, P., C. Esteves, C. Faro, and E. Pires. 1995. The vegetable
rennet of Cynara cardunculus L. contains two proteinases with
chymosin and pepsin-like specificities. Biotechnol. Lett.
17:621–626.
Vermeirssen, V., J. van Camp, and W. Verstraete. 2002. Optimization
and validation of an angiotensin-converting enzyme inhibition
assay for the screening of bioactive peptides. J. Biochem. Biophys.
Meth. 51:75–87.
Villa˜no, D., M. S. Ferna´ndez-Pacho´n, A. M. Troncoso, and M. C.
Garcı´a-Terrilla. 2004. The antioxidant activity of wines deter-
mined by ABTS•+ method: Influence of sample dilution and time.
Talanta 64:501–509.
